Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Robin Foà et al.|The Lancet Oncology|2014Cited by 1.3k
Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Ralf C. Bargou, Bernd Dörken|Journal of Clinical Investigation|1997Cited by 765
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathwayManik Chatterjee, Ralf C. Bargou|Blood|2002Cited by 100
Combined targeting of <scp>MEK</scp>/<scp>MAPK</scp> and <scp>PI</scp>3<scp>K</scp>/<scp>A</scp>kt signalling in multiple myelomaTorsten Steinbrunn, Ralf C. Bargou|British Journal of Haematology|2012Cited by 51
Abstract 1028: A tumor-agnostic YAP/TAZ score predicts TEAD inhibitor sensitivity independent of Hippo alterationsMichael Wegert-Verhoeven, Sebastian M. Dieter, Mathea Fransisca et al.|Cancer Research|2026Cited by 0